Media

BDSA’s Menu Analytics tool allows retailers to track in-stock and out-of-stock trends, COO Liz Stahura tells Benzinga.

For cannabis watchers, incremental steps are expected in the industry this year as opposed to big gains.

The 2022 midterms were a mixed bag for cannabis, with Maryland and Missouri being the bright spots as the 20th and 21st states to legalize adult-use cannabis.

New York is a massive market with 15 million-plus adult residents, BDSA chief executive Roy Bingham says.

What do CBD’s latest sales data tell us about consumer acceptance?

In the medical market, vapes have tied with flower for market share.

In this edition of "Rising High," The Fly conducted an exclusive interview with Roy Bingham, chief executive officer of BDSA, a Colorado-based cannabinoid market intelligence and consumer research firm. Here are some highlights:

The new year is upon us. The beginning of January always brings a sense of reflection, curiosity, and for many, hopeful anticipation about what’s possible over the next 12 months and beyond.

The legal U.S. marijuana industry is a mess.

There are reasons for hope, though. New and emerging adult-use markets in the Northeast region, as well as the Florida medical market, should show considerable growth next year.

State by state, cannabis legalization prospered in Western markets in 2022.

BDSA’s Retail Sales Tracking now tracks market performance across 14 U.S. markets.

In Michigan, the number of cultivators has doubled while prices have dropped by 75 percent.

Bingham shares the company’s predictions on where the cannabis industry will head in 2023 based on findings from its fall 2022 cannabis market forecast report.